Mutual of America Capital Management LLC Sells 4,170 Shares of CVS Health Co. (NYSE:CVS)

Mutual of America Capital Management LLC reduced its holdings in CVS Health Co. (NYSE:CVS) by 2.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 151,084 shares of the pharmacy operator’s stock after selling 4,170 shares during the quarter. Mutual of America Capital Management LLC’s holdings in CVS Health were worth $6,782,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. bought a new stake in CVS Health in the third quarter worth approximately $25,000. Ridgewood Investments LLC increased its holdings in CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 450 shares in the last quarter. Stonebridge Financial Group LLC bought a new stake in CVS Health in the fourth quarter worth approximately $28,000. Legacy Investment Solutions LLC bought a new stake in CVS Health in the third quarter worth approximately $31,000. Finally, Financial Perspectives Inc increased its holdings in shares of CVS Health by 137.5% during the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator’s stock valued at $36,000 after acquiring an additional 466 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Michael F. Mahoney purchased 30,000 shares of the company’s stock in a transaction dated Tuesday, February 18th. The shares were purchased at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the transaction, the director now directly owns 39,356 shares of the company’s stock, valued at approximately $2,625,045.20. This represents a 320.65 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.24% of the company’s stock.

CVS Health Stock Up 2.1 %

CVS stock opened at $65.85 on Monday. The stock’s fifty day simple moving average is $54.33 and its two-hundred day simple moving average is $56.47. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The stock has a market cap of $83.02 billion, a P/E ratio of 17.99, a P/E/G ratio of 0.98 and a beta of 0.61.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. Analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.04%. CVS Health’s dividend payout ratio is presently 72.68%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CVS. Cantor Fitzgerald upgraded CVS Health from a “neutral” rating to an “overweight” rating in a report on Wednesday, February 12th. Wells Fargo & Company boosted their price objective on CVS Health from $68.00 to $73.00 and gave the company an “overweight” rating in a report on Thursday, February 13th. JPMorgan Chase & Co. boosted their price objective on CVS Health from $80.00 to $81.00 and gave the company an “overweight” rating in a report on Tuesday, February 18th. Leerink Partnrs upgraded CVS Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 12th. Finally, StockNews.com upgraded CVS Health from a “sell” rating to a “hold” rating in a report on Thursday, February 13th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average price target of $69.83.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.